Literature DB >> 2595619

Second primary lung cancer: importance of long term follow up.

P C van Bodegom1, S S Wagenaar, B Corrin, J P Baak, J Berkel, R G Vanderschueren.   

Abstract

Review of histopathological and clinical data showed that 153 patients at one hospital developed a second primary lung cancer during 1980-6, 10% of all those with lung carcinoma. There were 64 synchronous tumours (interval less than one year) and 89 metachronous tumours (interval over one year). The average interval between metachronous tumours was 6.1 years. The criteria for diagnosing a second primary lung cancer were any of the following: (1) different histological type; (2) different lobe; (3) interval between the two tumours of at least three years. The incidence of second primary tumours increases with survival, and close follow up is required for their early detection.

Entities:  

Mesh:

Year:  1989        PMID: 2595619      PMCID: PMC1020843          DOI: 10.1136/thx.44.10.788

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Second primary bronchogenic carcinoma. A complication of successful lung cancer surgery.

Authors:  Y LE GAL; W C BAUER
Journal:  J Thorac Cardiovasc Surg       Date:  1961-01       Impact factor: 5.209

2.  Relationship of cell type and lymph node metastasis to survival after resection of bronchial carcinoma.

Authors:  T W Shields; J Yee; J H Conn; C D Robinette
Journal:  Ann Thorac Surg       Date:  1975-11       Impact factor: 4.330

3.  Sleeve lobectomy for carcinoma. A ten-year experience.

Authors:  R J Jensik; L P Faber; F J Milloy; J J Amato
Journal:  J Thorac Cardiovasc Surg       Date:  1972-09       Impact factor: 5.209

4.  Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron-supporting normal tissues.

Authors:  D J Schol; W J Mooi; A A van der Gugten; S S Wagenaar; J Hilgers
Journal:  Int J Cancer Suppl       Date:  1988

5.  [Double tumors in patients with a squamous cell carcinoma of the mucous membrane in the head and neck region].

Authors:  N de Vries; I van der Waal; G B Snow
Journal:  Ned Tijdschr Geneeskd       Date:  1985-09-07

6.  Multiple primary bronchial carcinomas.

Authors:  O Auerbach; A P Stout; E C Hammond; L Garfinkel
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

7.  Multiple primary lung cancers.

Authors:  N Martini; M R Melamed
Journal:  J Thorac Cardiovasc Surg       Date:  1975-10       Impact factor: 5.209

8.  Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer.

Authors:  B E Johnson; D C Ihde; M J Matthews; P A Bunn; A Zabell; R W Makuch; A Johnston-Early; M H Cohen; E Glatstein; J D Minna
Journal:  Am J Med       Date:  1986-06       Impact factor: 4.965

Review 9.  Tobacco and alcohol consumption in relation to the development of multiple primary cancers.

Authors:  E L Wynder; M H Mushinski; J C Spivak
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

10.  Incidence of miltiple primary cancers. IV. Cancers of the female breast and genital organs.

Authors:  D Schottenfeld; J Berg
Journal:  J Natl Cancer Inst       Date:  1971-01       Impact factor: 13.506

View more
  12 in total

1.  Synchronous double primary lung cancers of squamous and neuroendocrine type associated with cryptogenic fibrosing alveolitis.

Authors:  J W Seo; J G Im; Y W Kim; J H Kim; M N Sheppard
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

2.  Synchronous occurrence of an intermediate small cell and a bronchiolo-alveolar carcinoma of the lung.

Authors:  K Wong; E A Sankey; C DiSalvo; R K Walesby
Journal:  J R Soc Med       Date:  1993-10       Impact factor: 5.344

3.  Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer.

Authors:  Joe Y Chang; Yung-Hsien Liu; Zhengfei Zhu; James W Welsh; Daniel R Gomez; Ritsuko Komaki; Jack A Roth; Stephen G Swisher
Journal:  Cancer       Date:  2013-06-24       Impact factor: 6.860

4.  Synchronous papillary urothelial carcinoma of the bladder and squamous cell carcinoma with sarcomatoid differentiation: A case report.

Authors:  Mahizer Yaldiz; Nur Cihan Cosansu; Berna Solak; Zeynep Kahyaoglu; Mustafa Teoman Erdem
Journal:  Oncol Lett       Date:  2016-08-30       Impact factor: 2.967

5.  Risk Stratification for Second Primary Lung Cancer.

Authors:  Summer S Han; Gabriel A Rivera; Martin C Tammemägi; Sylvia K Plevritis; Scarlett L Gomez; Iona Cheng; Heather A Wakelee
Journal:  J Clin Oncol       Date:  2017-06-23       Impact factor: 44.544

6.  Synchronous primary lung cancers: prevalence in surgical material and clinical implications.

Authors:  F A Carey; S C Donnelly; W S Walker; E W Cameron; D Lamb
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

7.  Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors.

Authors:  Takaya Yamamoto; Keiichi Jingu; Yuko Shirata; Masashi Koto; Haruo Matsushita; Toshiyuki Sugawara; Masaki Kubozono; Rei Umezawa; Keiko Abe; Noriyuki Kadoya; Youjirou Ishikawa; Maiko Kozumi; Noriyoshi Takahashi; Ken Takeda; Yoshihiro Takai
Journal:  BMC Cancer       Date:  2014-06-23       Impact factor: 4.430

8.  [Clinical and Prognosic Anylasis of 30 Cases with Double Primary Lung Cancer].

Authors:  Ziqi Wang; Jingjing Hou; Huijuan Wang; Guowei Zhang; Zhiyong Ma
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-10-20

9.  Follow-up of an occult tuberculosis scar cancer after resection of metastatic lesions.

Authors:  Mengyao Sun; Yinghui Xu; Xu Wang; Chao Sun; Ye Guo; Guoguang Shao; Zhiguang Yang; Yunpeng Liu; Peng Zhang; Shi Qiu; Kewei Ma
Journal:  Thorac Cancer       Date:  2020-06-22       Impact factor: 3.500

10.  Adenocarcinoma of Lung and Bronchial Carcinoid Presenting as Double Synchronous Primary Lung Cancer: A Case Report and Review of Literature.

Authors:  Lakshmi Saladi; Sai Mounica Maddu; Masooma Niazi; Ajsza Matela
Journal:  World J Oncol       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.